Hypertension Diagnostics' CVProfilor® DO-2020 System Featured in Medical Bulletin Sent to American Academy of Family Physicians

ST. PAUL, MNOctober 2, 2001 Hypertension Diagnostics, Inc.  (NASDAQ SmallCap: HDII) announced today that a detailed article describing its primary product, the CVProfilor® DO-2020 CardioVascular Profiling System, is featured in the October 2001 issue of the Medco Forum®

 

   
The Medco Forum
® is a medical bulletin that presents new and innovative medical products and services to physicians and other health care providers. More than 35,000 copies of this publication, with the CVProfilor® featured as a lead cover article, were sent to physicians, medical professionals and members of the American Academy of Family Physicians (AAFP). The article explains how the CVProfilor® non-invasively determines the elasticity of both large and small arteries in adults and teens in order to assess cardiovascular disease risk. A complimentary reprint of the CVProfilor® article may be obtained by calling Hypertension Diagnostics, Inc. (HDI) or by visiting our website at: www.cvprofilor.com.

The mailing of this medical product bulletin was scheduled as a prelude to the AAFP Annual Scientific Assembly being held in Atlanta, GA from October 3-7, 2001. More than 5,000 family and primary care physicians as well as other medical personnel are expected to attend this convention, and HDI will be demonstrating the CVProfilor® at exhibit booth #’s 1540, 1542, and 1544 in the Georgia World Congress Center during the meeting.  

View .pdf version of the Bulletin

Hypertension Diagnostics, Inc. designs, develops, manufactures and markets proprietary cardiovascular profiling systems for medical applications and clinical research.  These systems are marketed to physicians, other health care professionals and researchers by a direct sales force and via distributors throughout the world. In addition to providing blood pressure values, the systems non-invasively detect subtle changes in the compliance or elasticity of both large and small arteries which is a unique feature of HDI’s technology.

Forward-looking statements in this press release are made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The Company wishes to caution readers not to place undue reliance on any forward-looking statements and to recognize that the statements are not a prediction of actual future results.  Actual results could differ materially from those presented and anticipated in the forward-looking statements due to the risks and uncertainties set forth in the Company’s 2000 Annual Report on Form 10-KSB, as amended, under the caption “Risk Factors,” as well as others not now anticipated.

CVProfilor is a registered trademark of Hypertension Diagnostics, Inc.
  
Hypertension Diagnostics, HDI/PulseWave, PulseWave and CVProfile are trademarks of Hypertension Diagnostics, Inc. All rights reserved.

Investor Relations: Jens Dalsgaard and Tony Altavilla,
Managing Directors
Redwood Consultants, LLC
Mill Valley, CA 94941
415-380-0500

Contact: Greg H. Guettler, President

Return to the Main HDI Newsroom

   

Back to Top

 

 

     

Copyright © 2010 Hypertension Diagnostics, Inc
Last revised Wednesday June 23, 2010
HDI Legal Information